glp-1 and gip/glp-1 receptor agonists Frontiers GLP-1 Receptor Agonists – Peripheral
Description
Sources for Figure 218
Outcomes included total and early-phase (060min) areas under the curve (AUCs) and peak concentrations
Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration
Method The PubMed (MEDLINE), EMBASE, Cochrane Library, and ClinicalTrials.gov databases were searched from the establishment of the database to December 24, 2022
Reddys Laboratories, shared his thoughts: The launch of Colozo marks a significant milestone in our gastrointestinal portfolio in India and builds on our legacy of introducing novel, first-in-class therapies following the successful launch of BixiBat last year
A major new study reveals that women who discontinued these medications gained over 3 kg more during pregnancy compared to those who never used them
